• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性糖尿病黄斑水肿中囊内高反射物质。

Intracystic hyperreflective material in centre-involving diabetic macular oedema.

机构信息

Department of Retina and Vitreous, Narayana Nethralaya, #121/C, 1st R Block, Chord Road, Rajaji Nagar, Bengaluru, Karnataka, 560010, India.

Medical Retina and Vitreoretinal Surgery, University of Pittsburgh School of Medicine, 203 Lothrop Street, Suite 800, Pittsburgh, PA, 15213, USA.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2533-2544. doi: 10.1007/s00417-021-05083-6. Epub 2021 Mar 12.

DOI:10.1007/s00417-021-05083-6
PMID:33710472
Abstract

PURPOSE

To report evolution and predictive value of intracystic hyperreflective material (ICHRM) on optical coherence tomography (OCT) in centre-involving diabetic macular oedema (CI-DME).

METHODS

Demographic and OCT features of patients with treatment-naïve CI-DME were analysed retrospectively. OCT parameters noted were macular oedema type, ICHRM presence, presence of hyperreflective spots, disorganised inner retinal layers and outer retinal layers integrity. Eyes were grouped into group 1 CI-DME without ICHRM and group 2 CI-DME with ICHRM. Univariate and multivariate linear regression analyses were done to study the correlation between various OCT features and final vision.

RESULTS

In this study, 62 eyes of 50 patients were included in group 1 and 61 eyes of 51 patients in group 2. Mean presenting logMAR vision in groups 1 and 2 was 0.374 ± 0.346 and 0.523 ± 0.369 respectively. Poor final visual acuity was noted in CI-DME with ICHRM group (p = 0.015). On linear regression analysis, 3 OCT features, namely, ICHRM presence (p = 0.034), inner segment-outer segment layer disruption (p = 0.001) and ellipsoid zone defects (p = 0.003), were associated with poor final vision. More intravitreal anti-VEGF (2.98 vs 0.629) and steroid (1.51 vs 0.242) injections were required for macular oedema resolution in ICHRM group.

CONCLUSION

This study is the first to assess the ICHRM on OCT as predictor for treatment outcome in DME eyes. We described its evolution during the DME management and its plausible influence on intravitreal therapy. We believe that this finding has the potential to become a novel biomarker for predicting the visual outcome in DME.

摘要

目的

报告中心性糖尿病黄斑水肿(CI-DME)中囊内高反射物质(ICHRM)在光学相干断层扫描(OCT)中的演变及其预测价值。

方法

回顾性分析未经治疗的 CI-DME 患者的人口统计学和 OCT 特征。记录的 OCT 参数包括黄斑水肿类型、ICHRM 存在、高反射点存在、内视网膜层紊乱和外视网膜层完整性。将眼分为无 ICHRM 的 CI-DME 组 1 和有 ICHRM 的 CI-DME 组 2。进行单变量和多变量线性回归分析,以研究各种 OCT 特征与最终视力之间的相关性。

结果

本研究中,50 例患者的 62 只眼纳入组 1,51 例患者的 61 只眼纳入组 2。组 1 和组 2 的初诊 logMAR 视力分别为 0.374±0.346 和 0.523±0.369。ICHRM 组的 CI-DME 最终视力较差(p=0.015)。在线性回归分析中,3 个 OCT 特征,即 ICHRM 存在(p=0.034)、内节-外节层中断(p=0.001)和椭圆体带缺损(p=0.003),与最终视力较差相关。ICHRM 组需要更多的玻璃体腔内抗 VEGF(2.98 与 0.629)和类固醇(1.51 与 0.242)注射以消退黄斑水肿。

结论

本研究首次评估了 OCT 上的 ICHRM 作为 DME 眼治疗结果的预测因子。我们描述了它在 DME 管理过程中的演变及其对玻璃体腔内治疗的可能影响。我们相信,这一发现有可能成为预测 DME 视力结果的新生物标志物。

相似文献

1
Intracystic hyperreflective material in centre-involving diabetic macular oedema.中心性糖尿病黄斑水肿中囊内高反射物质。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2533-2544. doi: 10.1007/s00417-021-05083-6. Epub 2021 Mar 12.
2
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.OCT 生物标志物作为经地塞米松植入物治疗的糖尿病性黄斑水肿的功能预后预测指标。
Ophthalmology. 2018 Feb;125(2):267-275. doi: 10.1016/j.ophtha.2017.08.031. Epub 2017 Sep 19.
3
Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.光学相干断层扫描生物标志物的时间变化可预测糖尿病性黄斑水肿抗血管内皮生长因子治疗的效果。
Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):807-815. doi: 10.1007/s00417-021-05387-7. Epub 2021 Oct 18.
4
MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.光学相干断层扫描渗漏测量在糖尿病性黄斑水肿中的应用:视力反应治疗的生物标志物。
Retina. 2019 Jan;39(1):52-60. doi: 10.1097/IAE.0000000000001905.
5
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.基线 SD-OCT 特征可预测糖尿病黄斑水肿模式,并可预测接受玻璃体内注射地塞米松植入物治疗的患者的形态学特征和复发时间。
Acta Diabetol. 2020 Jul;57(7):867-874. doi: 10.1007/s00592-020-01504-w. Epub 2020 Feb 29.
6
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.伴有视网膜下液的糖尿病性黄斑水肿中的高反射焦点:与抗血管内皮生长因子治疗后的视力结局的相关性。
Ophthalmic Res. 2023;66(1):39-47. doi: 10.1159/000525412. Epub 2022 Jun 13.
7
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.重复玻璃体内注射地塞米松治疗抗VEGF治疗无效的糖尿病性黄斑水肿:结果及频域光学相干断层扫描预测特征
Ophthalmologica. 2018;239(4):205-214. doi: 10.1159/000485852. Epub 2018 Feb 2.
8
Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.糖尿病性黄斑水肿患者玻璃体内注射类固醇和抗血管内皮生长因子治疗后的视网膜炎症生物标志物成像
Acta Ophthalmol. 2017 Aug;95(5):464-471. doi: 10.1111/aos.13294. Epub 2016 Oct 24.
9
Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.光学相干断层扫描模式可预测玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿后的视力预后。
Ophthalmology. 2007 May;114(5):890-4. doi: 10.1016/j.ophtha.2006.11.026.
10
Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.地塞米松治疗无反应性糖尿病性黄斑水肿:光学相干断层扫描生物标志物。
Acta Ophthalmol. 2019 Jun;97(4):e540-e544. doi: 10.1111/aos.13935. Epub 2018 Oct 14.

引用本文的文献

1
Detection of diabetic macular oedema patterns with fine-grained image categorisation on optical coherence tomography.利用光学相干断层扫描的细粒度图像分类检测糖尿病性黄斑水肿模式
BMJ Open Ophthalmol. 2025 Apr 15;10(1):e002037. doi: 10.1136/bmjophth-2024-002037.
2
Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study.比较多种病因引起的黄斑水肿的高反射病灶与谱域光相干断层扫描:一项观察性研究。
BMC Ophthalmol. 2022 Aug 29;22(1):352. doi: 10.1186/s12886-022-02575-9.
3
Diabetic Retinopathy and Diabetic Macular Edema in People With Early-Onset Diabetes.

本文引用的文献

1
Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema.外视网膜层的高反射焦点可预测雷珠单抗治疗糖尿病性黄斑水肿的功能疗效。
Sci Rep. 2020 Jan 21;10(1):873. doi: 10.1038/s41598-020-57646-y.
2
Relationship between diabetic macular edema and choroidal layer thickness.糖尿病性黄斑水肿与脉络膜层厚度的关系。
PLoS One. 2020 Jan 7;15(1):e0226630. doi: 10.1371/journal.pone.0226630. eCollection 2020.
3
Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
早发型糖尿病患者的糖尿病视网膜病变和糖尿病性黄斑水肿
Clin Diabetes. 2022 Spring;40(2):222-232. doi: 10.2337/cd21-0110. Epub 2022 Apr 15.
在中国,光学相干断层扫描(OCT)图像中的高反射灶作为糖尿病性黄斑水肿患者接受康柏西普治疗预后不良的生物标志物。
BMC Ophthalmol. 2019 Jul 23;19(1):157. doi: 10.1186/s12886-019-1168-0.
4
Multimodality analysis of Hyper-reflective Foci and Hard Exudates in Patients with Diabetic Retinopathy.多模态分析糖尿病视网膜病变患者的高反射焦点和硬性渗出物。
Sci Rep. 2017 May 8;7(1):1568. doi: 10.1038/s41598-017-01733-0.
5
Pearl necklace sign in diabetic macular edema: Evaluation and significance.糖尿病性黄斑水肿中的珍珠项链征:评估与意义
Indian J Ophthalmol. 2016 Nov;64(11):829-834. doi: 10.4103/0301-4738.195597.
6
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.糖尿病性黄斑水肿的病理生理学:血管源性与炎症性
J Diabetes Res. 2016;2016:2156273. doi: 10.1155/2016/2156273. Epub 2016 Sep 28.
7
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿:一项比较疗效随机临床试验的两年结果。
Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27.
8
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.雷珠单抗联合即时或延迟激光治疗与激光或曲安奈德联合延迟雷珠单抗治疗糖尿病性黄斑水肿的五年疗效
Am J Ophthalmol. 2016 Apr;164:57-68. doi: 10.1016/j.ajo.2015.12.025. Epub 2016 Jan 21.
9
Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.接受雷珠单抗治疗的糖尿病黄斑水肿患者的功能和解剖学结局的预测因素。
Ophthalmology. 2015 Jul;122(7):1395-401. doi: 10.1016/j.ophtha.2015.02.036. Epub 2015 Apr 11.
10
Solid-appearing retinal cysts in diabetic macular edema: a novel optical coherence tomography finding.糖尿病性黄斑水肿中表现为实性的视网膜囊肿:一种新型光学相干断层扫描发现
Retin Cases Brief Rep. 2013 Summer;7(3):255-8. doi: 10.1097/ICB.0b013e31828eef49.